Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A (2008). "The pharmacology of lysergic acid diethylamide: a review". CNS Neuroscience & Therapeutics. 14 (4). ss.295-314. doi:10.1111/j.1755-5949.2008.00059.x. PMC6494066. PMID19040555.
Halpern JH, Pope HG (Mart 2003). "Hallucinogen persisting perception disorder: what do we know after 50 years?". Drug and Alcohol Dependence. 69 (2). ss.109-19. doi:10.1016/S0376-8716(02)00306-X. PMID12609692.
Rogge T (21 Mayıs 2014), Substance use – LSD, MedlinePlus, U.S. National Library of Medicine, July 28, 2016 tarihinde kaynağından arşivlendiJuly 14, 2016
Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A (2008). "The pharmacology of lysergic acid diethylamide: a review". CNS Neuroscience & Therapeutics. 14 (4). ss.295-314. doi:10.1111/j.1755-5949.2008.00059.x. PMC6494066. PMID19040555.
Halpern JH, Pope HG (Mart 2003). "Hallucinogen persisting perception disorder: what do we know after 50 years?". Drug and Alcohol Dependence. 69 (2). ss.109-19. doi:10.1016/S0376-8716(02)00306-X. PMID12609692.
Rogge T (21 Mayıs 2014), Substance use – LSD, MedlinePlus, U.S. National Library of Medicine, July 28, 2016 tarihinde kaynağından arşivlendiJuly 14, 2016